Department of Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Department of Surgery, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Surg Endosc. 2023 Mar;37(3):1749-1755. doi: 10.1007/s00464-022-09692-y. Epub 2022 Oct 10.
Endoscopic ultrasound guided gastrojejunostomy (EUS-GJ) with lumen apposing metal stents has recently emerged as a viable option, as an alternative to surgical gastrojejunostomy and endoscopic enteral stenting, for managing gastric outlet obstruction (GOO). We aim to perform a retrospective analysis of the efficacy, safety and outcomes of EUS-GJ performed at three tertiary institutions in the United Kingdom.
Consecutive patients who underwent EUS-GJ between August 2018 and March 2021 were identified from a prospectively maintained database. Data were obtained from interrogation of electronic health records.
Twenty five patients (15 males) with a median age of 63 years old (range 29-80) were included for analysis. 88% (22/25) of patients had GOO due to underlying malignant disease. All patients were deemed surgically inoperable or at high surgical risk. Both technical and clinical success were achieved in 92% (23/25) of patients. There was an improvement in the mean Gastric Outlet Obstruction Scoring System scores following a technically successful EUS-GJ (2.52 vs 0.68, p < 0.01). Adverse events occurred in 2/25 patients (8%), both due to stent maldeployment necessitating endoscopic closure of the gastric defect with clips. Long-term follow-up data were available for 21 of 23 patients and the re-intervention rate was 4.8% (1/21) over a median follow-up period of 162 (range 5-474) days.
EUS-GJ in carefully selected patients is an effective and safe procedure when performed by experienced endoscopists.
内镜超声引导下胃空肠吻合术(EUS-GJ)联合使用腔内置入式金属支架,作为外科胃空肠吻合术和内镜肠内支架置入术的替代方法,已成为治疗胃出口梗阻(GOO)的一种可行选择。本研究旨在对英国三家三级医疗机构进行的 EUS-GJ 的疗效、安全性和结果进行回顾性分析。
从前瞻性维护的数据库中确定 2018 年 8 月至 2021 年 3 月期间接受 EUS-GJ 的连续患者。数据通过电子病历查询获得。
共纳入 25 例(15 例男性)患者,中位年龄为 63 岁(范围 29-80 岁)。88%(22/25)的患者因潜在恶性疾病而出现 GOO。所有患者均被认为无法手术或手术风险高。92%(23/25)的患者实现了技术和临床成功率。在技术上成功的 EUS-GJ 后,平均胃出口梗阻评分系统(Gastric Outlet Obstruction Scoring System)评分有所改善(2.52 分 vs 0.68 分,p<0.01)。25 例患者中有 2 例(8%)发生不良事件,均因支架放置不当导致内镜夹闭胃缺损。23 例中有 21 例(21/23)获得了长期随访数据,中位随访时间为 162 天(范围 5-474 天),再干预率为 4.8%(1/21)。
在经验丰富的内镜医生进行操作时,EUS-GJ 是一种有效且安全的方法,适用于精心挑选的患者。